These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8451910)

  • 1. Graves' disease, endocrine ophthalmopathy and smoking.
    Winsa B; Mandahl A; Karlsson FA
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):156-60. PubMed ID: 8451910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and risk of Graves' disease.
    Prummel MF; Wiersinga WM
    JAMA; 1993 Jan; 269(4):479-82. PubMed ID: 8419666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan.
    Chen YL; Chang TC; Chen CJ
    J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and thyroid disorders--a meta-analysis.
    Vestergaard P
    Eur J Endocrinol; 2002 Feb; 146(2):153-61. PubMed ID: 11834423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Graves' ophthalmopathy and smoking.
    Shine B; Fells P; Edwards OM; Weetman AP
    Lancet; 1990 May; 335(8700):1261-3. PubMed ID: 1971331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' ophthalmopathy and tobacco smoking.
    Tallstedt L; Lundell G; Taube A
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):147-50. PubMed ID: 8103953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin.
    Tellez M; Cooper J; Edmonds C
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):291-4. PubMed ID: 1563082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.
    Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does smoking increase relapse rates in Graves' disease?
    Kimball LE; Kulinskaya E; Brown B; Johnston C; Farid NR
    J Endocrinol Invest; 2002 Feb; 25(2):152-7. PubMed ID: 11929086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and prevention of Graves' ophthalmopathy.
    Wiersinga WM; Bartalena L
    Thyroid; 2002 Oct; 12(10):855-60. PubMed ID: 12487767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.
    Reddy SV; Jain A; Yadav SB; Sharma K; Bhatia E
    Indian J Med Res; 2014 Jan; 139(1):99-104. PubMed ID: 24604044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism.
    Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L
    Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
    Molnár I; Bokk A
    Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY; Ho SC; Seah LL; Fong KS; Khoo DH
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
    Wu YJ; Clarke EM; Shepherd P
    Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
    [